Answers are grounded in this paper and cite their sources.
In June 2013, the U.S. Supreme Court unanimously ruled that the patents on BRCA1 and BRCA2 held by Myriad were not valid because human genes are products of nature and therefore not patentable. The authors discuss the implications of this long-awaited decision.
No takes yet. Share an insight, caveat, or question.
Kesselheim et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: